Introduction
netics and pharmacodynamics. 3 Hypertension is a hemodynamic disorder present These and related issues were discussed in a either as a disease by itself or as a common recent symposium on the Island of Lanai, Hawaii. In accompaniment to many renal and neuroendocrine this symposium, which is published in the present diseases. An elevated arterial pressure is well issue, Dr John Flack reviews the epidemiology of known to accelerate the decline in the function of hypertension and its repercussions on the heart and target organs in diseases such as congestive heart kidney with regard to morbidity and mortality. Dr failure, diabetes and glomerulonephritis. In spite of John Burnett, Jr extends those findings to discuss the all the research examining the potential mechanisms pathophysiologic changes in the coronary endoinvolved in the genesis of hypertension and target thelium and its relationship to myocardial ischemia organ injury, to date there is still no cure. However, and heart failure. Drug metabolism in patients with numerous studies have identified risk factors not cardiac and renal disease was discussed by Dr Peter only for the development of hypertension, but also Meredith. Specifically, he underscores the imporfor target organ injury. Perhaps one of the key organs tance of peak:trough ratios and the treatment of BP that suffers the ravages of hypertension the most, in the post myocardial infarction and heart failure apart from the vasculature itself, is the heart. This is, settings. The importance of lipid control and its role in part, related to its inability to autoregulate arterial as a preventive measure in progression of cardiopressure over a large range of pressures. Consevascular disease along with treatment of BP is disquently, arterial hypertension has become the most cussed by Dr James Sowers. BP reduction is common cause of heart failure in the world today. 1 important and generally requires multiple mediNew information has emerged identifying the cations to achieve the recently recommended goal level of blood pressure (BP) control as a critical facof Ͻ130/85 mm Hg. A combination of drugs recently tor in certain ethnic subgroups with regard to preserappreciated to have synergistic protection with vation of renal function. Specifically, a recent retroregard to the kidney as well as the heart is that of spective analysis of the modification of dietary an ACE inhibitor with a calcium channel blocker, protein in renal disease (MDRD) trial demonstrated especially a non-dihydropyridine calcium channel that African-Americans with hypertension in renal blocker. 4 These issues are discussed in two separate disease required arterial pressure reductions to papers by our co-authors and ourselves. Lastly, carlevels of Ͻ125/75 mm Hg to achieve similar levels diac arrhythmias are a common accompaniment in of protection as were seen in Caucasians with BPs patients with hypertensive heart disease, and in of 135/85 mm Hg.
2 The reasons for a lower pressure many cases the selection of an antihypertensive requirement in the African-American subgroup are agent may be influenced not only by its antihyperunclear. Additional information has also been tensive but also by its electrophysiologic properties. obtained regarding differential metabolism of cerThis is discussed by Dr Peter Kowey. tain antihypertensive medications in sub-populations. Specifically, the effects of age and gender 
